CFD Research awarded FDA grant to study bioequivalence of ophthalmic drug products

Award

CFD Research was recently awarded a $400k research grant addressing the critical need for the development of computational tools to translate preclinical testing results from animals to humans for ophthalmic drug products. This project will provide researchers with a better understanding of the specific differences between animal and human eyes that result in differences in ocular drug distribution.

CFD Research awarded Army contract to develop model order reduction-based solver for thermal signature analysis

Award

CFD Research has been awarded a $1M Army contract to further develop an innovative Computational Fluid Dynamics (CFD) and Machine Learning (ML) based computational tool for accurate and rapid prediction of transient turbulent flow, heat transfer and thermal signatures. The survivability of military vehicles and their occupants often depends on efficient control of their thermal infrared (IR) signature as IR emissions, stemming from the thermal load, of military vehicles are used to detect, track, and lock-on to the target. Thermal modeling is typically used in order to predict and achieve performance goals related to the control of IR signatures.

CFD Research awarded Air Force contract for aeroelastic analysis of threat-damaged flight surfaces

Award

CFD Research Corporation announced today the award of a SBIR Phase II contract from the Air Force to create a novel, efficient, and accurate fully-coupled modeling approach for the aeroelastic analysis of threat-damaged flight surfaces. One of the key aircraft design requirements is aircraft survivability and vulnerability to damage caused by a variety of threat types. Damage which results in the physical removal of a portion of a wing or primary flight control surface undoubtedly leads to a reduction in aerodynamic performance and control degradation.

CFD Research awarded DTRA chemical warfare agent research contract

Award

CFD Research has received an award from the Defense Threat Reduction Agency to explore mechanisms, countermeasures and interventions for chemical warfare exposure. Chemical Warfare agents cause catastrophic medical disasters and have the ability to overwhelm any healthcare system. Extremely toxic, inexpensive and relatively easy to produce, these agents induce common cellular, molecular and inflammatory pathways resulting in acute inflammation, toxicity, and ultimately organ failure. CFD Research has a two-fold goal two-fold goal of identifying interventions nodes among the common inflammatory pathways while furthering identification of FDA approved drugs against these nodes. Known drugs will also be checked for their possibility in being a therapeutic target.